Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transmucosal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Transmucosal Drug Delivery device is intended for the localized delivery of medications through a mucous membrane.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Transmucosal Drug Delivery under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Transmucosal Drug Delivery and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Transmucosal Drug Delivery under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Transmucosal Drug Delivery Overview
3 Products under Development
3.1 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
3.2 Transmucosal Drug Delivery - Pipeline Products by Segment
3.3 Transmucosal Drug Delivery - Pipeline Products by Territory
3.4 Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
3.5 Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
3.6 Transmucosal Drug Delivery - Ongoing Clinical Trials
4 Transmucosal Drug Delivery - Pipeline Products under Development by Companies
4.1 Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
4.2 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
5 Transmucosal Drug Delivery Companies and Product Overview
6 Transmucosal Drug Delivery- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Tables
Transmucosal Drug Delivery - Pipeline Products by Stage of Development
Transmucosal Drug Delivery - Pipeline Products by Segment
Transmucosal Drug Delivery - Pipeline Products by Territory
Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
Transmucosal Drug Delivery - Ongoing Clinical Trials
Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
Transmucosal Drug Delivery - Pipeline Products by Stage of Development
Altamira Medica AG Pipeline Products & Ongoing Clinical Trials Overview
Bentrio - Viral Infections - Product Status
Bentrio - Viral Infections - Product Description
Altamira Medica AG - Ongoing Clinical Trials Overview
Bentrio - Viral Infections - A Randomized, Placebo-controlled Clinical Study to Evaluate the Ability of Bentrio Nasal Spray in COVID-19 Patients: COVAMID
Ryaltris Nasal Spray - A Phase III Clinical Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Ryaltris Compound Nasal Spray for the Treatment of Allergic Rhinitis or Rhinoconjunctivitis Symptoms in Patients
Grasses of Eden Ltd Pipeline Products & Ongoing Clinical Trials Overview
Montelukast VersaFilm - A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Use of Montelukast Versafilm for the Treatment of Parkinson’s Disease (PD)
International Partnership For Microbicides Pipeline Products & Ongoing Clinical Trials Overview
Dapivirine-Contraceptive Ring - Product Status
Dapivirine-Contraceptive Ring - Product Description
International Partnership For Microbicides - Ongoing Clinical Trials Overview
Dapivirine-Contraceptive Ring - A Randomized, Double-Blind, Phase 1b Study in Healthy HIV-Negative Women to Evaluate the Pharmacokinetics, Safety, and Bleeding Patterns Associated With 90-Day Use of Core-Sheath Vaginal Rings Releasing Dapivirine and Levonorgestrel
ITC Life Sciences and Technology Centre Pipeline Products & Ongoing Clinical Trials Overview
LYR-210 Transmucosal Delivery System - ENLIGHTEN 1: A Phase III, Randomized, Blinded, Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis (CRS) in Adults
LYR-210 Transmucosal Delivery System - ENLIGHTEN 2: A Phase III, Randomized, Blinded, Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults
Magee-Womens Research Institute Pipeline Products & Ongoing Clinical Trials Overview
EFdA-P+Progestin Intravaginal Film - Product Status
EFdA-P+Progestin Intravaginal Film - Product Description
NanaBis - An Observational Study Investigating and Auditing the Safety, Tolerability and Further Efficacy Characteristics of a Pharmaceutical Grade Cannabis Medicine (NanaBis) Prescribed to Eligible Patients for the Management of Cancer Related or Non-cancer Related Pain in General and Specialty Medical Practices